Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

1495P - Anxiety and depression in cancer patients receiving oncology treatment: Associated factors

Date

16 Sep 2021

Session

ePoster Display

Topics

Psychosocial Aspects of Cancer

Tumour Site

Presenters

Eleni Arvanitou

Citation

Annals of Oncology (2021) 32 (suppl_5): S1096-S1101. 10.1016/annonc/annonc710

Authors

E. Arvanitou1, E. Parpa2, E. Tsilika2, C. Christofyllakis1, N.G. Tsoukalas1, K. Mystakidou3

Author affiliations

  • 1 Oncology Department, 401 General Military Hospital of Athens, 115 27 - Athens/GR
  • 2 Palliative Care Unit, Department Of Radiology, University Areteion Hospital School of Medicine, Athens/GR
  • 3 Palliative Care Unit, Department Of Radiology, University Areteion Hospital School of Medicine, 115 27 - Athens/GR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1495P

Background

Cancer diagnosis is related to fear and is a source of great distress for patients. Anxiety and depression are common in cancer patients and seem to affect quality of life, treatment compliance and even survival. Demoralization, that encompass feelings of despair, loss of meaning and spiritual distress, can occur in patients with cancer. The aim of this study is to investigate the relationship between demoralization, anxiety, and depression and to examine demographic and clinical factors associated with anxiety and depression.

Methods

A convenience sample of 150 cancer inpatients and outpatients from two oncology centers, with various types of solid tumors, receiving oncology treatment, participated in a prospective cross-sectional observational study. The psychometric tools used were the Greek version of the Hospital Anxiety and Depression Scale (HAD) and the Demoralization Scale (DEMORALIZATION SCALE II, DS-II). The study was approved by the ethical committee or related boards of each hospital. Each patient was informed about the aims of the study and gave his/her written consent to participate.

Results

Patients mean age was 62 years (20-85 years) and 89 patients (59.3%) were women. Among patients, 33% had breast, 24% gastrointestinal and 15% lung cancer. A number of 82 patients (54,7%) had metastatic disease. Women showed higher rates of anxiety (p = 0.054). Anxiety was inversely related to age (p = 0.043) and positively correlated with time since diagnosis (p = 0.076). Unmarried patients presented higher rates of depression (p =0.026). Multiple linear regression showed a statistically significant impact of Demoralization on anxiety (p <0.001, R2 = 36.3%) and depression (p <0.001, R2 = 49%).

Conclusions

The results highlight the significant impact of demoralization on anxiety and depression in cancer patients. This emphasizes the need for empathy and apprehension of patients’ feelings by health care providers, to timely recognize feelings of despair and distress.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.